Sage Mountain Advisors LLC Trims Stake in Relx Plc $RELX

Sage Mountain Advisors LLC reduced its position in Relx Plc (NYSE:RELX) by 6.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,454 shares of the technology company’s stock after selling 394 shares during the quarter. Sage Mountain Advisors LLC’s holdings in Relx were worth $296,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Larson Financial Group LLC raised its position in Relx by 612.5% in the 1st quarter. Larson Financial Group LLC now owns 513 shares of the technology company’s stock worth $26,000 after purchasing an additional 441 shares during the period. WPG Advisers LLC purchased a new position in shares of Relx during the first quarter worth approximately $28,000. Golden State Wealth Management LLC increased its position in shares of Relx by 100.0% during the first quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company’s stock worth $30,000 after acquiring an additional 294 shares during the period. Caitong International Asset Management Co. Ltd increased its position in shares of Relx by 99.3% during the second quarter. Caitong International Asset Management Co. Ltd now owns 608 shares of the technology company’s stock worth $33,000 after acquiring an additional 303 shares during the period. Finally, Harbor Asset Planning Inc. purchased a new position in shares of Relx during the second quarter worth approximately $37,000. 15.02% of the stock is owned by hedge funds and other institutional investors.

Relx Trading Up 1.5%

Shares of RELX stock opened at $46.64 on Monday. The stock’s 50-day moving average is $46.62 and its 200 day moving average is $50.61. Relx Plc has a 1-year low of $44.19 and a 1-year high of $56.33. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 2.55.

Wall Street Analysts Forecast Growth

RELX has been the topic of a number of research reports. Wall Street Zen lowered shares of Relx from a “buy” rating to a “hold” rating in a research report on Friday, September 5th. Barclays reaffirmed an “overweight” rating on shares of Relx in a research report on Tuesday, October 7th. Kepler Capital Markets raised shares of Relx from a “hold” rating to a “strong-buy” rating in a research report on Thursday, September 18th. Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a research report on Thursday, September 11th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Relx in a research report on Saturday. One research analyst has rated the stock with a Strong Buy rating and five have issued a Buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy”.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.